Caption Management’s Gilead Sciences GILD Stock Holding History

Caption Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,900	Closed	-$6.06M	–	1761
2025 Q3	$5.54M	Sell	49,900 -98,700	-66%	-$11.2M	0.04%	456
2025 Q2	$16.5M	Buy	+148,600	New	+$15.8M	0.18%	112
2025 Q1	–	Sell	-20,000	Closed	-$2.06M	–	1712
2024 Q4	$1.85M	Buy	+20,000	New	+$1.8M	0.02%	718
2023 Q4	–	Sell	-7,500	Closed	-$584K	–	1459
2023 Q3	$562K	Buy	7,500 +2,000	+36%	+$154K	0.01%	909
2023 Q2	$424K	Sell	5,500 -1,825	-25%	-$146K	0.01%	848
2023 Q1	$608K	Buy	+7,325	New	+$607K	0.01%	751
2021 Q3	–	Sell	-130,000	Closed	-$9.13M	–	1610
2021 Q2	$8.95M	Buy	+130,000	New	+$8.68M	0.12%	223
2020 Q1	–	Sell	-20,000	Closed	-$1.3M	–	934
2019 Q4	$1.3M	Hold	20,000	–	–	0.04%	445
2019 Q3	$1.27M	Buy	+20,000	New	+$1.31M	0.07%	333

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caption Management's GILD Position: Q4 2025 in Review

Caption Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 49,900 shares — an estimated $6.06M sold.

Caption Management first reported a position in GILD in Q3 2019 and held it in 9 quarters. The position peaked at $16.5M in Q2 2025. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Caption Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
Caption Management sold 49,900 Gilead Sciences shares in Q4 2025, an estimated $6.06M.
Caption Management first reported a position in Gilead Sciences in Q3 2019 and held it in 9 quarters.
Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.